Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger [Yahoo! Finance]
Akero Therapeutics, Inc. (AKRO)
Last akero therapeutics, inc. earnings: 3/16 07:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to end at $54.08 apiece following announcements that it was set to merge with Novo Nordisk in a $5.2 billion deal. In a statement, Akero Therapeutics, Inc. (NASDAQ:AKRO) said both companies officially entered into a definitive agreement, under which Novo Nordisk would acquire all AKRO shares at a price of $54 apiece alongside a non-transferable contingent value right (CVR) upon the achievement of a milestone. Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger Each shareholder will be entitled to receive cash worth $6 upon full US regulatory approval of efruxifermin, a potential treatment for compensated cirrhosis due to MASH, by June 30, 2031. Akero Therapeutics, Inc. (NASDAQ:AKRO) said the offer price represents a 19 percent premium over its 30-day volume-weighted average price (VWAP), and a 42 percent premium to its closing price on May 19, prior to market speculation. Akero The
Show less
Read more
Impact Snapshot
Event Time:
AKRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKRO alerts
High impacting Akero Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AKRO
News
- Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKROBusiness Wire
- Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)PR Newswire
- Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]Yahoo! Finance
AKRO
Earnings
- 8/8/25 - Beat
AKRO
Sec Filings
- 12/3/25 - Form 8-K
- 11/28/25 - Form 4
- 11/26/25 - Form 4
- AKRO's page on the SEC website